Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762).

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Oncology

• Publication date

  2006-04-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2005.03.9289PMID 16567769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age does not influence taxol dose intensity in recurrent carcinoma of the ovary

  2010cited by this paper
• Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8.

  2005cited by this paper
• Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer).

  2005cited by this paper
• Taxanes in elderly breast cancer patients.

  2004cited by this paper
• Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer

  2004cited by this paper
• Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.

  2004cited by this paper
• Weekly Paclitaxel in Elderly Patients with Advanced Breast Cancer

  2004cited by this paper
• Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer.

  2003cited by this paper
• A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863.

  2003cited by this paper
• Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?

  2003cited by this paper
• Comparative pharmacokinetics of unbound paclitaxel during 1- and 3-hour infusions.

  2002cited by this paper
• Weekly Paclitaxel in Women Age 65 and Above with Metastatic Breast Cancer*

  2002cited by this paper
• Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients.

  2001cited by this paper
• A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer.

  2001cited by this paper
• Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer.

  2001cited by this paper
• Frailty in older adults: evidence for a phenotype.

  2001cited by this paper
• Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

  2000cited by this paper
• Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

  1999cited by this paper
• Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.

  1998cited by this paper
• Age and cytochrome P450‐linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions

  1997cited by this paper
• Cancer burden in the aged

  1997cited by this paper
• Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.

  1995cited by this paper
• Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors.

  1995cited by this paper
• Limited Sampling Strategies for Investigating Paclitaxel Pharmacokinetics in Patients Receiving 175 mg/m2 as a 3-Hour Infusion

  1995cited by this paper
• The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer

  1994cited by this paper
• Cancer pharmacology in the elderly.

  1993cited by this paper
• Geriatric pharmacology: basic and clinical considerations.

  1992cited by this paper
• Categorical Data Analysis

  1991cited by this paper
• Longitudinal Studies on the Rate of Decline in Renal Function with Age

  1985cited by this paper
• Clinical trials and drug toxicity in the elderly. The experience of the eastern cooperative oncology group

  1983cited by this paper
• Average Partial Association in Three-way Contingency Tables: a Review and Discussion of Alternative Tests

  1978cited by this paper
• Lehmann, E. L., Nonparametrics: Statistical Methods Based on Ranks, San Francisco. Holden‐Day, Inc., 1975. 480 S., $ 22.95 .

  1977cited by this paper
• Nonparametrics: Statistical Methods Based on Ranks

  1975cited by this paper
• Adult lean body mass declines with age: some longitudinal observations.

  1970cited by this paper
• Age differences in the water content of the body as related to basal oxygen consumption in males.

  1963cited by this paper
• Anatomy of body water and electrolytes.

  1959cited by this paper

• Impact of sarcopenia on paclitaxel-induced peripheral neuropathy in early-stage breast cancer: a prospective observational study (the neuro-sarc study)

  2025cites this paper
• The quest to define cancer-specific systems parameters for personalized dosing in oncology

  2025cites this paper
• My Career in Geriatric Oncology.

  2025cites this paper
• Advantages, barriers, and cues to advance care planning engagement in elderly patients with cancer and family members in Southern Thailand: a qualitative study

  2024cites this paper
• Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition.

  2023cites this paper
• Research on the Effects of Chemotherapy on Survival Outcomes for Older Patients with Primary Triple-Negative Breast Cancer after Surgery: A Propensity Score Matching and Competing Risk Analysis of the SEER Database

  2023cites this paper
• Pharmacokinetic Modeling Using Real‐World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target Achievement–Clinical Outcomes Relationship

  2023cites this paper
• Model‐based approach to identify predictors of paclitaxel‐induced myelosuppression in “real‐world” administration

  2023cites this paper
• Chemotherapy dosing in older adults with cancer: One size does NOT fit all.

  2022cites this paper
• Clinical management of chemotherapy for elderly gynecological cancer patients

  2021cites this paper
• From Assessment to Implementation and Beyond in Cancer and Aging Research.

  2021cites this paper
• Tumors: Gynecology

  2020cites this paper
• Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?

  2019cites this paper
• Principles of Chemotherapy in Older Adults

  2019cites this paper
• Impact of Older Age on the Exposure of Paclitaxel: a Population Pharmacokinetic Study

  2019cites this paper
• Biologic Mechanisms Linked to Prognosis in Ovarian Cancer that May Be Affected by Aging

  2019cites this paper
• Progress Through Collaboration: An ASCO and U.S. Food and Drug Administration Workshop to Improve the Evidence Base for Treating Older Adults With Cancer.

  2018cites this paper
• Age and the Risk of Paclitaxel‐Induced Neuropathy in Women with Early‐Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101

  2018cites this paper
• Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for Chemotherapy-Induced Cumulative Neutropenia

  2017influential citation
• Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.

  2017cites this paper
• Advancing Treatment Approach to the Older Patient with Cancer Through Clinical Trials Participation.

  2017cites this paper
• Are phase I trials safe for older patients?

  2017cites this paper
• Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted Therapies.

  2016cites this paper
• Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer

  2016cites this paper
• Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force.

  2016cites this paper
• Targeted chemotherapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in metastatic breast cancer: which benefit for which patients?

  2016cites this paper
• Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional age.

  2015cites this paper
• Chemotherapy of ovarian cancer in elderly patients

  2015cites this paper
• Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes.

  2015cites this paper
• Epithelial ovarian cancer in older women: defining the best management approach.

  2015cites this paper
• How I treat ovarian cancer in older women.

  2014cites this paper
• Prescribing for older patients with cancer.

  2014cites this paper
• Personalizing medicine in geriatric oncology.

  2014cites this paper
• Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century".

  2014cites this paper
• Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations.

  2014cites this paper
• Treatment and trials: ovarian cancer in older women.

  2013cites this paper
• Expression of CD133 in acute leukemia

  2013cites this paper
• Considerations Regarding the Administration of Systemic Therapy for Elderly Patients With Ovarian Cancer

  2013cites this paper
• The impact of medication therapy management in older oncology patients

  2013cites this paper
• Enhancement of baicalin by hexamethylene bisacetamide on the induction of apoptosis contributes to simultaneous activation of the intrinsic and extrinsic apoptotic pathways in human leukemia cells.

  2013cites this paper
• Pharmacology of aging and cancer: how useful are pharmacokinetic tests?.

  2013cites this paper
• Chemotherapy in Older Adults with Cancer

  2013cites this paper
• Ovarian Cancer: Primary Chemotherapy

  2013cites this paper
• Pharmacology of Chemotherapy

  2013cites this paper
• Management of gynecological cancers in older women

  2013cites this paper
• Impact of the Physiological Effects of Aging on the Pharmacokinetics and Pharmacodynamics of Systemic Lung Cancer Treatment

  2013cites this paper
• Expression of CD 133 in acute leukemia

  2013cites this paper
• Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?

  2013cites this paper
• Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840.

  2012cites this paper
• Biological, clinical, and psychosocial correlates at the interface of cancer and aging research.

  2012cites this paper
• Doublet chemotherapy in the elderly patient with ovarian cancer.

  2012cites this paper
• Clinical trial design in older adults with cancer—The need for new paradigms

  2012cites this paper
• Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

  2012cites this paper
• Chapter 9 – Chemotherapy

  2012cites this paper
• Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

  2012cites this paper
• Therapeutic management of breast cancer in the elderly

  2011cites this paper
• Treatment of the Elderly Head and Neck Cancer Patient

  2011cites this paper
• Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults

  2011cites this paper
• Impact of the Physiological Effects of Aging on the Pharmacokinetics and Pharmacodynamics of Systemic Breast Cancer Treatment

  2010cites this paper
• AC133 Expression in Egyptian Children With Acute Leukemia: Impact on Treatment Response and Disease Outcome

  2010cites this paper
• Impact of age, sex, and comorbidity on cancer therapy and disease progression.

  2010cites this paper
• Low-level detection of anti-cancer drug in blood plasma using microwave-treated gold-polystyrene beads as surface-enhanced Raman scattering substrates.

  2010cites this paper
• Taxanes in the elderly: can we gain as much and be less toxic?

  2009cites this paper
• Competition of alternative and complementary therapy Chemotherapy in the elderly : are their needs being met ? PeRsPective

  2009cites this paper
• Aging and Cancer: What Oncologists Need to Know

  2009cites this paper
• Chemotherapy for the Older Adult with Cancer

  2009cites this paper
• Pharmacology and Pharmacogenetics of Chemotherapeutic Agents

  2009cites this paper
• The effect of comorbidity on survival in patients with advanced ovarian cancer

  2009cites this paper
• Chemotherapy for Ovarian Cancer in the Older Adult

  2009cites this paper
• Chemotherapy in the elderly: are their needs being met?

  2009cites this paper
• Management of Head and Neck Cancer in Elderly Patients

  2009cites this paper
• Older patients and the shifting focus of cancer care.

  2009cites this paper
• NCCN Task Force Report: breast cancer in the older woman.

  2008cites this paper
• Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials

  2008cites this paper
• Tomorrow's cancer treatments today: the first 50 years of the Cancer and Leukemia Group B.

  2008cites this paper
• Clinical pharmacology of cancer therapies in older adults

  2008cites this paper
• Anticancer Drug Therapy in the Older Cancer Patient: Pharmacology and Polypharmacy

  2008cites this paper
• Retrospective review of cancer patients > or =80 years old treated with chemotherapy at a comprehensive cancer center.

  2008cites this paper
• Ovarian cancer in older women.

  2008cites this paper
• Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy.

  2007cites this paper
• Adjuvant Treatment of Breast Cancer in Older Patients

  2007cites this paper
• Pharmacokinetics of chemotherapy in the older patient.

  2007cites this paper
• Clinical trials in older adults with cancer: past and future.

  2007cites this paper
• International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.

  2007cites this paper
• Tolerance to chemotherapy in elderly patients with cancer.

  2007cites this paper
• Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacy.

  2007cites this paper
• Role of Adjuvant Therapy in Older People with Breast Cancer

  2007cites this paper
• Cancer in the elderly population: the protection racket.

  2006cites this paper
• Treating advanced breast cancer in the older woman.

  2006cites this paper
• The Cancer and Leukemia Group B Cancer in the Elderly Committee: Addressing a Major Cancer Need

  2006cites this paper
• Determination of free concentration of Paclitaxel in liposome formulation.

  2006cites this paper
• The Cancer and Leukemia Group B Pharmacology and Experimental Therapeutics Committee: A Historical Perspective

  2006cites this paper
• Chemotherapy in the elderly.

  2004cites this paper